EX-99.1 2 dex991.htm PRESS RELEASE DATED SEPTEMBER 3, 2009 Press Release dated September 3, 2009

Exhibit 99.1





Amedisys, Inc.

Director of Investor Relations

Kevin LeBlanc

(225) 292-2031



Amedisys Announces Executive Changes

BATON ROUGE, Louisiana (September 3, 2009)—Amedisys, Inc. (NASDAQ: “AMED” or the “Company”), one of America’s leading home health and hospice nursing companies, today announced that two executives are leaving the Company to pursue other interests. The Company has accepted the resignation of Mr. Larry R. Graham, as President and Chief Operating Officer of the Company. The resignation is effective September 3, 2009. Mr. Graham’s duties will be temporarily assumed by William F. Borne, the Company’s Chairman and Chief Executive Officer.

The Company also announced the departure of Chief Information Officer Alice Ann Schwartz, effective September 3, 2009.

“We are grateful to Larry and Alice Ann for their contributions throughout the years,” said Mr. Borne. “We anticipate a seamless transition, as we have a first-class team of seasoned professionals that are ready and able to guide our future growth strategies. We believe our future in healthcare has never been brighter.”

Amedisys, Inc. is headquartered in Baton Rouge, Louisiana. Its common stock trades on the Nasdaq Global Select Market under the symbol “AMED”.

This press release includes statements that may constitute “forward-looking” statements, usually containing the words “believe”, “estimate”, “project”, “expect”, “anticipate” or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Many of the factors that could cause or contribute to such differences are described in the Company’s periodic reports and registrations statements filed with the Securities and Exchange Commission, and include, but are not limited to the following: general economic and business conditions, changes in or failure to comply with existing regulations or the inability to comply with new government regulations on a timely basis, changes in Medicare and other medical reimbursement levels, ability to complete acquisitions announced from time to time, and any financing related thereto, the ability to meet debt service requirements and to comply with covenants in debt agreements, adverse changes in federal and state laws relating to the health care industry, demographic changes, availability and terms of capital, ability to attract and retain qualified personnel, ongoing development and success of new start-ups, ability to successfully integrate newly acquired agencies, changes in estimates and judgments associated with critical accounting policies, business disruption due to natural disasters or acts of terrorism, and various other matters, many of which are beyond management’s control. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.

Our company website address is www.amedisys.com. We use our website as a channel of distribution for important company information. Important information, including press releases, analyst presentations and financial information regarding the Company is routinely posted on and accessible on the “Investor Relations” subpage of our website, which is accessible by clicking on the tab labeled “Investors” on our website home page. We will also use our website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the Securities and Exchange Commission (“SEC”) disclosing the same information. In addition, we make available on the Investor Relations subpage of our website (under the link “SEC filings”) free of charge our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, ownership reports on Forms 3, 4 and 5 and any amendments to those reports as soon as practicable after we electronically file such reports with the SEC. Further, copies of our Certificate of Incorporation and Bylaws, our Code of Ethical Business Conduct and the charters for the Audit, Compensation and Nominating and Governance Committees of our Board are also available on the Investor Relations subpage of our website (under the link “Corporate Governance”).

Additional information on the Company can be found at: